SO
Swedish Orphan Biovitrum Stock: price and insider trades · Sweden
ISIN SE0020846285SE·
No insider purchase over the last 90 days. The latest, by Norbert Oppitz, was filed 18 Sept 2023.
Swedish Orphan Biovitrum: what insiders have been doing
We have very little insider data for Swedish Orphan Biovitrum so far: the most recent filing dates from 18 September 2023. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€4
1 ops. · all time
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 18 September 2023
Declarations2 total
- 5 shares@ SEK 10.500.0% of flowTeckningsrätt/UniträttISIN SE0020846285FI:csv-0c18352b93622721c866Canonical exit: 4 Dec 2023 (T+90)
- 4,967 shares@ SEK 142.00100.0% of flowBTA (betald tecknad aktie)ISIN SE0020846293FI:csv-a58c53e7e9076c4c865c
2 of 2 declarations
About Swedish Orphan Biovitrum
Swedish Orphan Biovitrum is a biopharmaceutical company focused on developing treatments for rare diseases. It is listed on the Stockholm Stock Exchange.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations